Lin Y, Berdeja J, Raje N, et al. First-in-human multicenter study of BB2121 anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma: updated results. EHA 2017, abstract 142.
Primaire auto-immuun hemolytische anemie geassocieerd met ischemisch CVA
feb 2024 | Benigne hematologie, Neuro-vasculair